In its recent annual report (AIFA, 2020a), AIFA published aggregated reports for MP in some therapeutic areas of interest such as: chronic hepatitis C, age-related macular degeneration, family hypercholesterolemia (PCSK9) on the characteristics of the patients treated, and prescribing centers in the regions. The gene discussed is PCSK9; the disease is chronic hepatitis C virus infection.